Heart rhythm registry aims to uncover hidden risks in AF patients
NCT ID NCT07437456
First seen Jun 27, 2026 · Last updated Sep 11, 2026 · Updated 1 time
Summary
This registry will follow 3,500 adults with atrial fibrillation who have a low risk of stroke. Researchers will track complications like stroke and hospitalizations over time to see how patients are managed in everyday medical practice. The goal is to better understand outcomes and treatments in this specific group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 3,500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2026
- Expected to finish
-
Jan 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Anonymized male and female patients aged 18 to 64 years suffering from atrial fibrillation confirmed by a specialist, with a CHA₂DS₂-VASc score ranging from 0 to 2 for men and from 1 to 3 for women.
- Ages
-
18 to 64 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Retrospective Part The retrospective part will include patients who attended a physician consultation for atrial fibrillation three years ago and who met the inclusion criteria at that time. Inclusion criteria for the retrospective part: * Male or female patients aged 18 to 64 years at the time of data registration; * Presence of a specialist-confirmed diagnosis of atrial fibrillation; * CHA₂DS₂-VASc score ranging from 0 to 2 for men and from 1 to 3 for women. Non-inclusion criteria for the retrospective part: * Age under 18 years; * Age over 64 years; * CHA₂DS₂-VASc score greater than 2 for men and greater than 3 for women; * Inability to undergo screening examination and follow-up; * Organ or tissue transplantation less than 5 years prior to study enrollment; * Open heart surgery (coronary artery bypass grafting, valve replacement, reconstructive aortic surgery) within 6 months prior to study enrollment; * Established diagnosis of dementia of any severity and/or established diagnosis of moderate or severe encephalopathy, as well as other conditions precluding independent regular medication intake. Prospective Part Inclusion criteria for the prospective part: * Male or female patients aged 18 to 64 years at the time of data registration; * Presence of a specialist-confirmed diagnosis of atrial fibrillation; * CHA₂DS₂-VASc score ranging from 0 to 2 for men and from 1 to 3 for women at the time of screening. Non-inclusion criteria for the prospective part: * Age under 18 years; * Age over 64 years; * CHA₂DS₂-VASc score greater than 2 for men and greater than 3 for women; * Inability to undergo screening examination and follow-up; * Organ or tissue transplantation less than 5 years prior to study enrollment; * Open heart surgery (coronary artery bypass grafting, valve replacement, reconstructive aortic surgery) within 6 months prior to study enrollment; * Established diagnosis of dementia of any severity and/or established diagnosis of moderate or severe encephalopathy, as well as other conditions precluding independent regular medication intake. Exclusion criteria: * Patient withdrawal of consent for further participation in the study; * Identification of factors precluding further patient participation in the study (at the physician's discretion).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Atrial fibrillation (AF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Eurasian Association of Therapists
Moscow, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a checklist and heart monitor stop repeat strokes?
- Can a breathing workout and walks help dialysis patients with irregular heartbeats?
- Zapping the ear: a new way to stop Post-Surgery heart rhythm problems?
- Can a new mapping and ablation system fix recurring atrial fibrillation?
- Can shedding pounds stop atrial fibrillation in its tracks?
- Pacemaker algorithm tuned to Heart's pumping may beat standard rate response